Vornorexant - Taisho Pharmaceutical
Alternative Names: ORN-0829; TS-142Latest Information Update: 01 Oct 2025
At a glance
- Originator Taisho Pharmaceutical
- Class Fluorinated hydrocarbons; Oxazines; Pyrazoles; Pyridines; Sleep disorder therapies; Small molecules; Triazoles
- Mechanism of Action Orexin receptor type 1 antagonists; Orexin receptor type 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Insomnia
- No development reported Sleep apnoea syndrome